b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">31171481</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>04</Month>\n            <Day>16</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>08</Month>\n            <Day>01</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1938-0682</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>17</Volume>\n                    <Issue>4</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>08</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Clinical genitourinary cancer</Title>\n                <ISOAbbreviation>Clin Genitourin Cancer</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>275-282.e1</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S1558-7673(19)30139-9</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clgc.2019.04.013</ELocationID>\n            <Abstract>\n                <AbstractText Label="BACKGROUND">Germline genetic testing increasingly identifies advanced prostate cancer (PCa) patients who are candidates for precision therapies. The Prostate Cancer Clinical Trials Consortium (PCCTC) established the Germline Genetics Working Group to provide guidance and resources to expand effective use of germline genetic testing.</AbstractText>\n                <AbstractText Label="MATERIALS AND METHODS">A 14-item questionnaire was e-mailed to academic oncologists at 43 PCCTC sites to collect information on germline genetic testing patterns, including patients considered, choice of assays, barriers slowing adoption, and actions to overcome barriers.</AbstractText>\n                <AbstractText Label="RESULTS">Twenty-six genitourinary oncologists from 19 institutions responded. Less than 40% (10 of 26) reported referring patients to a genetics department, whereas the remainder take personal responsibility for genetic testing and counseling; 16 (62%) consider testing all metastatic PCa patients, whereas 3 (12%) consider testing all patients with high-risk local disease; and 7 (27%) use multigene comprehensive pan-cancer panels, and 14 (54%) use smaller or targeted cancer gene panels. Barriers to widespread use are: (1) delayed or limited access to genetic counseling; (2) no insurance coverage; (3) lack of effective workflows; (4) insufficient educational materials; and (5) time and space constraints in busy clinics. The primary limitation was the\xc2\xa0&lt;50% (19 of 43) response from PCCTC sites and no coverage of nonacademic cancer treatment facilities.</AbstractText>\n                <AbstractText Label="CONCLUSION">Joint efforts by urologists, oncologists, genetics counselors, insurers, and cancer centers can accelerate implementation of integrated germline genetic services for personalized treatment and clinical trial eligibility for PCa patients.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2019 Elsevier Inc. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Paller</LastName>\n                    <ForeName>Channing J</ForeName>\n                    <Initials>CJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Sidney Kimmel Comprehensive Cancer Center, Department of Urology, Johns Hopkins University, Baltimore, MD.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Antonarakis</LastName>\n                    <ForeName>Emmanuel S</ForeName>\n                    <Initials>ES</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Sidney Kimmel Comprehensive Cancer Center, Department of Urology, Johns Hopkins University, Baltimore, MD.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Beer</LastName>\n                    <ForeName>Tomasz M</ForeName>\n                    <Initials>TM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Hematology/Medical Oncology School of Medicine, Oregon Health and Science University Knight Cancer Institute, Portland, OR.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Borno</LastName>\n                    <ForeName>Hala T</ForeName>\n                    <Initials>HT</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicine, University of California San Francisco/Helen Diller Family Cancer, San Francisco, CA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Carlo</LastName>\n                    <ForeName>Maria I</ForeName>\n                    <Initials>MI</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>George</LastName>\n                    <ForeName>Daniel J</ForeName>\n                    <Initials>DJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Medical Oncology, Department of Medicine and Duke Cancer Institute, Duke University Medical Center, Durham, NC.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Graff</LastName>\n                    <ForeName>Julie N</ForeName>\n                    <Initials>JN</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Hematology and Medical Oncology, VA Portland Health Care System/Oregon Health &amp; Science University Knight Cancer Institute, Portland, OR.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Gupta</LastName>\n                    <ForeName>Shilpa</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Hematology, Oncology, and Transplantation, University of Minnesota Masonic Cancer Center, Minneapolis, MN.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Heath</LastName>\n                    <ForeName>Elisabeth I</ForeName>\n                    <Initials>EI</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Karmanos Cancer Institute and Department of Oncology, Wayne State University, Detroit, MI.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Higano</LastName>\n                    <ForeName>Celestia S</ForeName>\n                    <Initials>CS</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Fred Hutchinson Cancer Research Center and Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>McKay</LastName>\n                    <ForeName>Rana R</ForeName>\n                    <Initials>RR</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicine, University of California at San Diego Moores Cancer Center, La Jolla, CA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Morgans</LastName>\n                    <ForeName>Alicia K</ForeName>\n                    <Initials>AK</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Hematology/Oncology, Department of Medicine, Feinberg School of Medicine at Northwestern University, Chicago, IL.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Patnaik</LastName>\n                    <ForeName>Akash</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicine, University of Chicago Comprehensive Cancer Center, Chicago, IL.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Petrylak</LastName>\n                    <ForeName>Daniel P</ForeName>\n                    <Initials>DP</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Urology, Yale Cancer Center, New Haven, CT.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Rettig</LastName>\n                    <ForeName>Matthew B</ForeName>\n                    <Initials>MB</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ryan</LastName>\n                    <ForeName>Charles J</ForeName>\n                    <Initials>CJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Hematology, Oncology, and Transplantation, University of Minnesota Masonic Cancer Center, Minneapolis, MN.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Taplin</LastName>\n                    <ForeName>Mary-Ellen</ForeName>\n                    <Initials>ME</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Whang</LastName>\n                    <ForeName>Young E</ForeName>\n                    <Initials>YE</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicine, Hematology/Oncology, University of North Carolina Lineberger Cancer Center, Chapel Hill, NC.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Vinson</LastName>\n                    <ForeName>Jacob</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Prostate Cancer Clinical Trials Consortium, Memorial Sloan Kettering Cancer Center, New York, NY.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Cheng</LastName>\n                    <ForeName>Heather H</ForeName>\n                    <Initials>HH</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Fred Hutchinson Cancer Research Center and Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA. Electronic address: hhcheng@uw.edu.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Giri</LastName>\n                    <ForeName>Veda N</ForeName>\n                    <Initials>VN</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA. Electronic address: Veda.Giri@jefferson.edu.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <CollectiveName>PCCTC Germline Genetics Working Group</CollectiveName>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>K23 CA197526</GrantID>\n                    <Acronym>CA</Acronym>\n                    <Agency>NCI NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n                <Grant>\n                    <GrantID>P30 CA006973</GrantID>\n                    <Acronym>CA</Acronym>\n                    <Agency>NCI NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n                <Grant>\n                    <GrantID>P30 CA008748</GrantID>\n                    <Acronym>CA</Acronym>\n                    <Agency>NCI NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n                <Grant>\n                    <GrantID>UL1 TR002319</GrantID>\n                    <Acronym>TR</Acronym>\n                    <Agency>NCATS NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n                <Grant>\n                    <GrantID>UL1 TR001863</GrantID>\n                    <Acronym>TR</Acronym>\n                    <Agency>NCATS NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n                <Grant>\n                    <GrantID>P50 CA097186</GrantID>\n                    <Acronym>CA</Acronym>\n                    <Agency>NCI NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D016448">Multicenter Study</PublicationType>\n                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n                <PublicationType UI="D013486">Research Support, U.S. Gov\'t, Non-P.H.S.</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>04</Month>\n                <Day>18</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>Clin Genitourin Cancer</MedlineTA>\n            <NlmUniqueID>101260955</NlmUniqueID>\n            <ISSNLinking>1558-7673</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D005817" MajorTopicYN="N">Genetic Counseling</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005820" MajorTopicYN="Y">Genetic Testing</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D018095" MajorTopicYN="Y">Germ-Line Mutation</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006280" MajorTopicYN="N">Health Workforce</DescriptorName>\n                <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D017057" MajorTopicYN="N">Medically Uninsured</DescriptorName>\n                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D058990" MajorTopicYN="N">Molecular Targeted Therapy</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D057285" MajorTopicYN="N">Precision Medicine</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011471" MajorTopicYN="N">Prostatic Neoplasms</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012017" MajorTopicYN="N">Referral and Consultation</DescriptorName>\n                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">BRCA</Keyword>\n            <Keyword MajorTopicYN="Y">DNA repair</Keyword>\n            <Keyword MajorTopicYN="Y">Lynch</Keyword>\n            <Keyword MajorTopicYN="Y">PARP inhibitors</Keyword>\n            <Keyword MajorTopicYN="Y">Pembrolizumab</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>03</Month>\n                <Day>05</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>04</Month>\n                <Day>11</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>6</Month>\n                <Day>7</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>4</Month>\n                <Day>17</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>6</Month>\n                <Day>8</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31171481</ArticleId>\n            <ArticleId IdType="pii">S1558-7673(19)30139-9</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.clgc.2019.04.013</ArticleId>\n            <ArticleId IdType="pmc">PMC6662206</ArticleId>\n            <ArticleId IdType="mid">NIHMS1530986</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>J Genet Couns. 2018 Feb;27(1):16-20</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29052810</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Genitourin Cancer. 2018 Oct;16(5):385-391</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29937067</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2015 Jun 25;372(26):2509-20</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26028255</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Prostate. 2018 Aug;78(11):775-789</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29717499</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2015 Apr 20;33(12):1397-406</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25779564</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Prostate. 2019 Mar;79(4):333-339</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30450585</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>JCO Precis Oncol. 2018;2018:</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30761386</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Urol. 2018 Mar;199(3):683-690</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29203269</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Med Genet C Semin Med Genet. 2018 Mar;178(1):24-37</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29512888</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur Urol. 2016 Jun;69(6):992-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26724258</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2015 Oct 29;373(18):1697-708</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26510020</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Genet Couns. 2012 Apr;21(2):151-61</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22134580</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>JAMA Oncol. 2019 Apr 1;5(4):523-528</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30730552</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Cancer Res. 2014 Feb 1;20(3):764-75</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24240112</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2018 Feb 1;36(4):414-424</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29236593</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2009 Feb 20;27(6):986-93</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19075281</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Nucl Med. 2018 May;59(5):733-739</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29523631</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur Urol. 2015 Aug;68(2):186-93</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25454609</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2015 Nov 1;33(31):3660-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26324357</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2016 Aug 4;375(5):443-53</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27433846</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur Urol. 2019 May;75(5):743-749</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30309687</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Science. 2017 Jul 28;357(6349):409-413</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28596308</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2018 Jun 19;9(47):28561-28571</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29983880</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'